- Home
- Equities - Stocks - Shares
- Company Press Releases
- Aqua Bio Technology: Minutes From Extraordinary General Meeting - Completion of Private Placement and The Jetcarrier Transaction
Aqua Bio Technology: Minutes from extraordinary general meeting - Completion of Private Placement and the Jetcarrier Transaction
13 Nov 2024 13:59 CET
Issuer
Aqua Bio Technology ASA
13.11.2024 13:59:25 CET | Aqua Bio Technology ASA | Additional regulated
information required to be disclosed under the laws of a member state
Aqua Bio Technology ASA ("ABT" or the "Company") has today held an extraordinary
general meeting. All resolutions were made in accordance with the proposals set
out in the notice for the extraordinary general meeting which means that the
Private Placement and Jetcarrier Transaction announced on
17 October have been completed. The minutes of the extraordinary general meeting
are attached to this notice.
Following the Jetcarrier Transaction, ABT owns all the shares in Jetcarrier AS
which owns 100 % of the shares in Jetcarrier Logistics AS, Isebakkeveien 75 AS,
Jetcarrier Solutions AS, Xpanz AS, Norlane AS, Jetcarrier AB, FreightWay AB and
Filial Magnoas, and represents a major logistic group in the Nordics.
For further information, please contact Jan Varming, CFO, telephone +47 90 83 90
76.
About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skincare products. ABT's cosmetics ingredients are
highly effective, and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skincare products developed by partners towards consumers and
professional users. ABT's focus on commercialization and development of natural
ingredients and natural skincare products has been, and will continue to be, an
important part of the Company's strategy going forward. ABT is listed on the
Euronext Expand market of the Oslo Stock Exchange.
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
DISCLOSURE REGULATION
This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.
ABOUT AQUA BIO TECHNOLOGY ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/18322224/5241/Download%20announce
ment%20as%20PDF.pdf
Aqua Bio Technology ASA - Minutes of EGM 13 November 2024_37_.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/18322224/5240/Aqua%20Bio%20Techno
logy%20ASA%20-%20Minutes%20of%20EGM%2013%20November%202024_37_.pdf
More information:
Access the news on Oslo Bors NewsWeb site
632080_Aqua Bio Technology ASA - Minutes of EGM 13 November 2024_37_.pdf
632080_Download announcement as PDF.pdf
Source
Aqua Bio Technology ASA
Provider
Oslo Børs Newspoint
Company Name
AQUA BIO TECHNOLOGY
ISIN
NO0010307135
Symbol
ABTEC
Market
Euronext Expand